Science and technology improves human health but the pressure for faster and larger improvements is increasing in this area. A fundamental starting point for better understanding the impact of innovation on health is the measurement of research and development.
Dans un monde en rapide évolution, le progrès des nations, des sociétés et des individus est probablement plus que jamais lié à leur capacité d'adaptation au changement, ainsi qu'à leur capacité d'acquisition et de partage des connaissances. Cet ouvrage précise les concepts de capital humain et de capital social, et évalue leur incidence sur la croissance économique et le bien-être. Le concept de capital social est encore assez peu
View a large number of reports from this high-level forum, including a discussion of knowledge management policies and practices in Denmark.
English, , 61kb
The purpose of the present chapter is to describe the flow of employees into and out of the higher educational system from and into the surrounding economy.
This paper compares venture capital activity across OECD countries by taking into account international venture capital flows.
Achieving sustainable development goals at a global level will strongly depend on the rapid development and widespread application of cleaner technologies. But do developing countries have the capacity and motivation to take advantage of cleaner technology options?
Across the OECD, attention is focusing increasingly on what has been dubbed the "digital divide" - a term that refers to the gaps in access to information and communication technology (ICT). The stakes are high, as ICT is now integral to the soci...
English, , 20kb
The aims of the seminar are to advance our understanding of knowledge management at organisation and enterprise levels across sectors in the emerging knowledge economy and to develop a framework identifying good practices of knowledge management in enterprises and organisations across sectors. <
This working paper summarises the information gathered by the OECD Secretariat as part of its work to obtain an accurate assessment of the current state of biotechnology statistics in OECD member and observer countries.
This document attempts to quantify the aggregate net effect of government funding on business R&D in 17 OECD member countries over the past two decades.